Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF). (2022)
Attributed to:
Reducing the risk of post-hepatectomy liver failure using a novel MRI method to predict post-operative function.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1161/circulationaha.122.059851
PubMed Identifier: 35877829
Publication URI: http://europepmc.org/abstract/MED/35877829
Type: Journal Article/Review
Volume: 146
Parent Publication: Circulation
Issue: 4
ISSN: 0009-7322